Median Technologies, a provider of healthcare imaging solutions and services, received approval from the European Investment Bank to draw down the final tranche of the loan granted on December 18, 2019, and renegotiated at the end of 2022.
Cellectis entered into the warrant agreement and finalized the related ancillary documents required under the credit facility with the European Investment Bank (EIB) for up to €40 million ($43.7 million).
ExeVir Bio, a biotech company developing robust nanobody therapies for broad protection against infectious diseases, secured a venture debt financing agreement of up to €25 million ($26.7 million) with the European Investment Bank.
Cellectis, a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, entered into a €40 million ($42.5 million) credit facility agreement with the European Investment Bank (EIB).
SES, a provider of global content connectivity solutions, entered into a €300 million ($318.2 million) term loan with the European Investment Bank.
MedinCell secured an additional €20 million ($19.8 million) in financing from European Investment Bank. The bullet credit facility agreement will take over from a previous €20 million ($19.8 million) loan granted in 2018 by European Investment Bank.
Cubic Telecom has secured $26.4 million in new funding from the European Investment Bank, the world’s largest international public bank.
Nokia completed a €500 million ($543 million) loan with the European Investment Bank, supported by the European Fund for Strategic Investments. Nokia will use the loan to further accelerate its research and development of 5G technology.
Ericsson signed a credit facility agreement of €250 million ($292.7 million) with the European Investment Bank.